Article Details

Rhythm Pharmaceuticals Presents New Data from Phase 2 Basket Study Showing Continued ...

Retrieved on: 2021-03-20 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Rhythm Pharmaceuticals Presents New Data from Phase 2 Basket Study Showing Continued .... View article details on HISWAI: https://www.globenewswire.com/news-release/2021/03/20/2196506/0/en/Rhythm-Pharmaceuticals-Presents-New-Data-from-Phase-2-Basket-Study-Showing-Continued-Weight-Loss-at-Up-to-Nine-Months-in-Patients-with-HET-Obesity-on-Setmelanotide-at-ENDO-2021.html

Excerpt

Mean weight loss among responders was -10.1 percent at three months. New data presented at ENDO 2021 included an analysis that showed that, ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up